Oyster Point Pharma, Inc.
OYSTDelisted Jan 3, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001720725
Oyster Point Pharma, Inc. was delisted on Jan 3, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 53 institutions reported holding it in 13F filings for Q4 2022, worth $189.4M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Oyster Point Pharma, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 69 | 80 | +11 |
| Shares | 17.8M | 20.8M | +2.98M (+16.8%) |
| Value | $210.8M | $378.8M | +$167.9M (+79.7%) |
New holders (23)
Institutions that held Oyster Point Pharma, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cowen and Company, LLC | 509,794 | $9.31M | 0.89% |
| KPCB XIV Associates, LLC | 367,987 | $6.72M | 4.17% |
| Paradigm Biocapital Advisors LP | 304,238 | $5.55M | 1.59% |
| Sio Capital Management, LLC | 181,857 | $3.32M | 1.01% |
| Pura Vida Investments, LLC | 41,130 | $751.0K | 0.08% |
| Alps Advisors Inc | 30,276 | $553.0K | 0.01% |
| Susquehanna International Group, LLP | 28,021 | $512.0K | 0.00% |
| Jane Street Group, LLC | 17,911 | $327.0K | 0.00% |
| Virtu Financial LLC | 17,842 | $326.0K | 0.03% |
| Dimensional Fund Advisors LP | 16,042 | $293.0K | 0.00% |
| ACG Wealth | 14,212 | $260.0K | 0.04% |
| Vontobel Holding Ltd. | 10,303 | $188.0K | 0.00% |
| Lazard Asset Management LLC | 4,545 | $82.0K | 0.00% |
| Wells Fargo & Company | 3,851 | $70.0K | 0.00% |
| UBS Group AG | 3,598 | $66.0K | 0.00% |
| Hershey Trust Co | 3,003 | $55.0K | 0.00% |
| Gibson Wealth Advisors LLC | 1,100 | $20.0K | 0.02% |
| Cutler Group LP | 621 | $11.0K | 0.00% |
| Quantbot Technologies LP | 500 | $9.00K | 0.00% |
| Advisor Group Holdings, Inc. | 250 | $5.00K | 0.00% |
| Huntington National Bank | 123 | $2.00K | 0.00% |
| Daiwa Securities Group Inc. | 76 | $1.00K | 0.00% |
| Mass General Brigham, Inc | 2,102 | $1.00K | 0.00% |
Sold out (12)
Institutions that held Oyster Point Pharma, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Vida Ventures Advisors, LLC | 640,070 | $7.58M |
| AlphaCentric Advisors LLC | 98,500 | $1.17M |
| Gsa Capital Partners LLP | 49,422 | $586.0K |
| Jacobs Levy Equity Management, Inc | 31,204 | $370.0K |
| Marshall Wace, LLP | 27,946 | $331.0K |
| Parametric Portfolio Associates LLC | 23,778 | $282.0K |
| Price T Rowe Associates Inc | 17,028 | $202.0K |
| HighTower Advisors, LLC | 10,912 | $129.0K |
| Belvedere Trading LLC | 9,047 | $125.0K |
| Public Employees Retirement System of Ohio | 1,616 | $19.0K |
| Point72 Hong Kong Ltd | 1,190 | $14.0K |
| MCF Advisors LLC | 1,072 | $13.0K |